MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

NCT02560220 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

BIOLOGICAL: Mitomycin C-induced peripheral blood mononuclear cells (MICs)

Sponsor

Heidelberg University

Collaborators

[object Object]
[object Object]